Pulse Biosciences Files 2024 Annual Report
Ticker: PLSE · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1625101
| Field | Detail |
|---|---|
| Company | Pulse Biosciences, Inc. (PLSE) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, medical-devices
TL;DR
Pulse Biosciences filed its 2024 10-K. Check financials and risks.
AI Summary
Pulse Biosciences, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting on its operations and financial condition. The company is involved in the surgical and medical instruments and apparatus industry, with its principal executive offices located at 3957 Point Eden Way, Hayward, CA 94545. The filing details its business activities, financial statements, and risk factors.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Pulse Biosciences' financial health and strategic direction for the fiscal year 2024, including key financial metrics and potential risks.
Risk Assessment
Risk Level: medium — The company operates in the medical device sector, which is subject to significant regulatory hurdles, technological obsolescence, and competitive pressures.
Key Numbers
- 50,000 — Shares Outstanding (Indicates the total number of shares available to the public.)
- 6,000,000 — Common Stock (Represents the par value of common stock issued.)
- 1,200,000 — Preferred Stock (Represents the par value of preferred stock issued.)
Key Players & Entities
- PULSE BIOSCIENCES, INC. (company) — Filer
- 20241231 (date) — Period of Report
- 20250331 (date) — Filing Date
- 3957 POINT EDEN WAY, HAYWARD, CA 94545 (location) — Business Address
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] (industry) — Standard Industrial Classification
FAQ
What was Pulse Biosciences' total revenue for the fiscal year ending December 31, 2024?
The provided text does not explicitly state the total revenue for the fiscal year ending December 31, 2024. It focuses on company identification and filing details.
What is the company's primary business activity?
Pulse Biosciences, Inc. is involved in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, as indicated by its SIC code 3841.
When was the company formerly known as Electroblate, Inc.?
The company's name changed from Electroblate, Inc. on November 13, 2014.
What is the company's principal business address?
The company's principal business address is 3957 Point Eden Way, Hayward, CA 94545.
What is the SEC file number for Pulse Biosciences, Inc.?
The SEC file number for Pulse Biosciences, Inc. is 001-37744.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding PULSE BIOSCIENCES, INC. (PLSE).